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Abstract
Background: Premenstrual disorders usually refer to premenstrual syndrome (PMS) and premenstrual dysphoric
disorder (PMDD). This study was designed to evaluate health-related quality of life (HRQOL) in a sample of Iranian
adolescents with premenstrual disorders.
Methods: This was a cross sectional study. A sample of adolescent schoolgirls aged between 14 and 19 years were
included in the study. Premenstrual disorders were indicated according to the International Classification of
Diseases (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Health-related quality of
life was measured using the Short Form Health Survey (SF-36). The data were analyzed in a descriptive fashion and
were compared among subgroups of the study sample.
Results: In all 602 female students were studied. All students reported at least one premenstrual symptom. Of
these, 224 (37.2%) met the diagnostic criteria for premenstrual dysphoric disorder (PMDD). Comparing the SF-36
scores between female students with and without PMDD, it was found that there were significant differences
between these two groups in all measures (P < 0.001) except for physical functioning (P = 0.274). These differences
were more evident on role emotional, role physical, social functioning and bodily pain.
Conclusion: The study findings affirm the fact that adolescents with premenstrual disorders suffer from poor
health-related quality of life. In order to improve quality of life in female adolescents appropriate support should
be provided for this population especially for those who suffer from more severe premenstrual disorders.
Background
Premenstrual disorders namely premenstrual syndrome
(PMS) and premenstrual dysphoric disorder (PMDD),
are a group of physical, cognitive, affective, and beha-
vioral symptoms that occur cyclically during the luteal
phase of the menstrual cycle and resolve at or within a
few days of the onset of menstruation [1]. The common
symptoms of PMS and PMDD include swelling, breast
tenderness, aches, headache, bloating, sleep disturbances,
appetite change, poor concentration, decreased interest,
social withdrawal, irritability, mood swings, anxiety/
tension, depression, and feeling out of control [2]. Of
these, six symptoms identified as core symptoms sug-
gesting that clinical diagnosis of PMS can be developed
around a core symptom group. The identified core
symptoms are: anxiety/tension, mood swings, aches,
appetite/food cravings, cramps, and decreased interest in
activities [3]. However, although it has been estimated
that a high proportion of women in reproductive age
(up to 90%) experience some degree of premenstrual
symptoms, the diagnosis of PMS or PMDD is assigned
to those women whose lives are significantly affected by
moderate to severe symptoms [4]. As noted by Rapkin
and Mikacich premenstrual disorders likely start in the
teen years and at least 20% of adolescents may experi-
ence moderate-to-severe premenstrual symptoms. They
indicated that the literature suggests that a similar
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PMDD [4,5].
Premenstrual symptoms might cause several difficul-
ties for women including impairment in physical func-
tioning, psychological health and severe dysfunction in
social or occupational realms [6]. In young adolescents
symptoms might particularly affect school functions,
and social interactions in a negative way [7]. Previous
studies have also shown that women with premenstrual
disorders have a poor health-related quality of life
[8-10]. In a comprehensive review of the literature Par-
kin and Winer distinguished four types of studies that
evaluated the PMS/PMDD effect on health-related qual-
ity of life and for instance reported that ‘the affective,
behavioral and physical symptoms of PMDD have been
shown to adversely affect health-related quality of life to
a disabling degree, especially regarding interpersonal
relationships with family members and partner’ or
‘women with PMDD suffer impairment that is as severe
as women with chronic clinical depression and that
their luteal phase adjustment to social and leisure activ-
ities is even worse than women with other types of
depression’ [9].
It is believed that improvements in HRQOL reduces
the complications associated with this disorder, or at
least makes it more tolerable. To attain this goal, we
must first assess quality of life in adolescents in order to
tailor the concept of HRQOL to this population and
integrate these into a comprehensive plan for care. The
purpose of this study was to assess health-related quality
of life (HRQOL) in a sample of Iranian adolescents with
premenstrual disorders (PMS and PMDD). It was hoped
that this preliminary study could contribute to the exist-
ing knowledge on the topic and provide necessary infor-
mation for possible future interventions.
Methods
The study sample and design
A cross sectional study was conducted in Sabzevar
boarding high schools. Sabzevar is a city in Khorasan
province, located in the east of Iran. There are only
three boarding high schools in the city. All students in
these high schools were invited to participate in the
research. Students with irregular menstrual cycles, cur-
rent major medical and psychological problems, those
receiving hormonal therapy and experiencing a cata-
strophe shortly before or during the study were
excluded from the study.
Quality of life measure
Quality of life was measured using the Short Form
Health Survey (F-36). The SF- 36 is a generic instru-
ment that consists of eight subscales: physical function-
ing, role physical, bodily pain, general health, vitality,
social functioning, role emotional, and mental health.
Scores in each subscale range from zero to 100, with
zero representing the worst HRQOL and 100 represent-
ing the best possible score. Previous evaluations of the
original as well as the Persian version of the SF-36 indi-
cated good reliability and construct validity [11].
Additional measures
1. The Symptom Check List (SCL-90-R) [12] to exclude
students with probable severe psychological disorders
due to other reasons. As such students with score
greater than 63 (the cut-off point on the SCL-90-R)
considered to suffer from severe depression and anxiety
and were excluded from the study.
2. A designed questionnaire based on the ICD-10 for
PMS diagnosis. According tot h eI C D - 1 0af e m a l es u f -
fering from at least one distressing premenstrual symp-
tom could be regarded as having PMS [13].
3. A designed questionnaire based on Diagnostic and
Statistical Manual, 4th edition (DSM-IV) for PMDD
diagnosis [14].
4. A questionnaire for collecting data on demographic
and menstrual characteristics of the study sample. This
questionnaire consisted of 2 parts. Part 1 included ques-
tions about socio-demographic information such as age,
marital status, parents’ employment, and economic sta-
tus. Part 2 included questions about menstrual charac-
teristics such as the severity of menstrual bleeding, the
length of menstrual bleeding, menstrual cycle duration,
the presence of dysmenorrhea and age of menarche. An
additional question was also designed in this part to
evaluate the awareness of the students about premenstr-
ual disorders.
Statistical analysis
T h ed a t aw e r ea n a l y z e di nad e s c r i p t i v ef a s h i o n .A l s o
univariate analysis of variance was performed to com-
pare age adjusted quality of life data between adoles-
cents with and without PMDD.
Ethics
The Ethics Committee of Tarbiat Modares University
approved the study. All participants gave their written
consent.
Results
In all there were 636 female students. Of these, 18 stu-
dents were absent. All the remaining students (n = 618)
agreed to participate in the study. However, 602 stu-
dents (94.6%) met the inclusion criteria. The mean age
of participants was 15.78 (SD = 1.06) years (ranging
from 14 to 19 years). The mean age of menarche was
12.99 (SD = 1.13) years. The mean duration of men-
strual bleeding was 7.2 (SD = ± 3.31) days and the
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days. Students scores on the Symptom Check List (SCL-
90-R) was 1.45 (SD = 0.72) ranging from 0.03 to 3.24.
The characteristics of the participants are shown in
Table 1.
All participants met the ICD-10 diagnostic criteria for
PMS and 37.2% were suffering from PMDD according
to the DSM-IV diagnostic criteria.
The comparisons of the SF-36 scores among students
with and without PMDD are shown in Table 2. Students
with PMDD scored significantly lower in all measures (P
< 0.0001) except for physical functioning (P < 0.274)
indicating that PMDD significantly affected their health-
related quality of life. The differences were more evident
on role emotional, role physical, social functioning and
bodily pain.
Discussion
The findings from this study showed that students with
PMDD reported a poor health-related quality of life as
measured by the SF-36. They specially reported poorer
conditions on role emotional, role physical, social
functioning and bodily pain. Similarly a recent publica-
tion using the SF-12v2 (the shortened version of the SF-
36) found that women either at risk for PMS or PMDD
were significantly more likely to report limitations than
women with no indication of PMS in all health-related
quality of life areas except for two physical functioning
Table 1 Demographic and menstrual characteristics of the study sample (n = 602)
With PMS (n = 602) Without PMDD (n = 378) With PMDD (n = 224)
No. (%) No. (%) No. (%)
Age groups (year)
14-15 265 (44) 172 (45.4) 93 (41.7)
16-17 311(52) 192(50.8) 119 (53)
18-19 26 (4) 14 (3.8) 12 (5.3)
Mean (SD) 15.76 (1.06) 15.70 (1.04) 15.86 (1.09)
Age at menarche (year)
9-10 7 (1) 3 (0.8) 4 (1.8)
11-12 198 (33) 124 (32.7) 74 (32.9)
13-14 356 (59) 220 (58.2) 136 (60.8)
15-16 41 (7) 31 (8.3) 10 (4.5)
Mean (SD) 12.99 (1.13) 13.03 (1.16) 12.93 (1.07)
Marital status
Single 541 (90) 340 (89.9) 201 (89.7)
Married 61 (10) 38 (10.1) 23 (10.3)
Dysmenorrhea
Yes 505 (84) 307 (81.2) 198 (88.3)
No 97 (16) 71 (18.8) 26 (11.7)
Severity of menstrual bleeding
Mild 38 (6.3) 25 (6.6) 13 (5.8)
Moderate 412 (68.4) 272 (71.9) 140 (62.3)
Severe 152 (25.3) 81 (21.5) 71 (31.8)
Scores on the SCL-90-R
Mean (SD) 1.45 (0.72) 1.26 (0.57) 1.49 (0.82)
Range 0.03-3.24 0.34-2.27 0.03-3.24
Table 2 Comparison of the SF-36 scores in adolescents
with and without PMDD*
Without PMDD
(n = 378)
With PMDD
(n = 224)
Mean (SD) Mean (SD) P
Physical functioning 81.96 (20.20) 79.74 (21.87) 0.274
Role physical 74.35 (29.95) 52.27 (34.77) < 0.001
Bodily pain 73.37 (20.04) 58.11(23.41) < 0.001
General health 69.47 (15.88) 61.22 (16.02) < 0.001
Social functioning 77.62 (19.84) 61.30 (21.24) < 0.001
Role emotional 69.71 (35.12) 43.65 (38.29) < 0.001
Vitality 64.33 (17.82) 53.92 (17.14) < 0.001
Mental health 69.09 (16.85) 58.20 (18.70) < 0.001
*Adjusted for age
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item [15]. Although some investigators showed that that
physical and mental premenstrual symptoms have simi-
lar significant impact on quality of life as measured by
a c t i v i t i e so fd a i l yl i f e[ 1 6 , 1 7 ]o rf o u ro ft h ef i v em o s t
prevalent premenstrual symptoms were found to be
physical [18]; it is argued that physical symptoms are an
important component of premenstrual syndromes, but
these have been shown to be psychobiological in nature
[19]. A study of the burden of premenstrual dysphoric
disorder (PMDD) on health-related quality of life found
that the burden of PMDD was greater on mental and
emotional health-related quality of life domains than on
physical health-related quality of life domains. The dis-
ease burden of PMDD on health-related quality of life
was estimated by comparing SF-12v2 scores between
women who were identified as being at risk for PMDD
with those observed in the general U.S. female popula-
tion [20].
Similar to the current study tow other investigations
in Iran and Pakistan used the SF-36 to measure health-
related quality of life in female adolescents who suffered
from PMS and both found that quality of life was signif-
icantly lower in the affected group [21,22]. The former
study compared quality of life in a sample of the second
year high schoolgirls with and without PMS and found
that there were only significant differences between
those who suffered from severe PMS and healthy ado-
lescents on mental health and vitality. The differences
among healthy adolescents and those who suffered from
mild and moderate PMS and for other measures on the
SF-36 were not significant. It is argued that female ado-
lescents with severe PMS might experience more stress
and thus report poorer conditions. A study comparing
w o m e ni nt w od i f f e r e n tg r o u p s( h i g ha n dl o wP M S
groups) revealed that women in the high PMS group
had significantly more stress and poorer quality of life
than women in the low PMS group [23]. However, in
comparison with other studies participants in our study
scored higher on all measures indicating that they had a
better quality of life. These differences are difficult to
interpret but might be due to different life styles, socioe-
conomic status or cultures [7,21-23].
The finding from this study also revealed that PMS was
common among female students. All participants in the
present study had reported at least one symptom of PMS.
Similarly a study from Iran revealed that 98.2% of univer-
sity students aged 18-27 years were experiencing at least
one mild to severe premenstrual symptom [24]. Overall
evidence suggests that PMS is a common disorder
among Asian adolescents. A Turkish study reported that
61.4% of adolescent girls suffer from PMS [25] and Lee et
al. also found that 76% of Chinese female undergraduates
reported at least one premenstrual symptom [26]. A
cross-sectional survey of 1,295 rural adolescent girls aged
13 to 19 years in Malaysia showed that most participants
(63.1%) identified themselves as having premenstrual
symptoms [27]. However agreement on using similar cri-
teria and a standard measure to assess premenstrual dis-
orders in adolescents might be a solution for the problem
of such differences in reporting. As such a recent publi-
cation suggested that the Premenstrual Symptoms
Screening Tool modified for adolescents (PSST-A) is a
fast, and reliable tool to screen for these syndromes in
adolescents [28]. For instance a study from Sri Lanak
determining PMS by the PSST-A and American College
of Obstetricians and Gynecologists (ACOG) diagnostic
criteria reported that individual premenstrual symptoms
were experienced by 65.7% of schoolgirls but the preva-
lence of PMS was only 8.75% [29].
A New developed instruments for evaluating the
impact of premenstrual symptoms on HRQOL make the
importance of our study more outstanding. The Pre-
menstrual Symptoms Impact Survey (PMSIS), a web-
based instrument administered to 971 women aged 18-
45 years, revealed that the PMSIS scores differed
between women with high, average or low health-related
quality of life as measured by the SF-12 physical and
mental component scores. Wallenstein and colleagues
concluded that the PMSIS could be used to distinguish
different clinical groups and assess the impact of symp-
toms on HRQOL [30].
Limitations
There were some limitations inherent to this study.
Firstly, all students reported at least one premenstrual
symptom and thus according to the ICD-10 criteria we
identified all as having premenstrual syndrome. One
should be cautious that our data was self-reported and
more importantly using different criteria might lead to
different results. A study found that 54% of adolescents
aged 13 to 18 years said that they had PMS but only
31% met the diagnostic criteria [31]. Secondly, using a
generic measure to assess health-related quality of life
among this population rather than using a disease-speci-
fic tool such as the Premenstrual Symptoms Impact Sur-
vey (PMSIS) makes the findings limited. In addition,
school functioning is an important issue among adoles-
cents. The SF-36 ignores such a dimension and one
should use well-known instruments to assess health-
related quality of life among children and adolescents (e.
g .t h eP e d i a t r i cQ u a l i t yo fL i f eI n v e n t o r y -P e d s Q L ) .
However, at commence of the present study none of
these instruments were available in Iran.
Conclusion
The findings from this study confirmed that adolescents
with PMS/PMDD suffer from a poor HRQOL. The
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were more significant in those with PMDD. The find-
ings suggest that health and educational authorities
need to recognize the problem and provide appropriate,
tangible and emotional support for female students with
premenstrual disorders at schools especially for those
who suffer from PMDD. In addition, there is need to
establish and strengthen school-based reproductive
health education programs to enable female students to
learn how to deal with these disturbing problems.
Indeed future research should focus primarily on imple-
mentation and evaluation of school-based health educa-
tion programs on the topic.
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